Latest News
Ultima Genomics UG200 Sequencing Platform selected for SG-INSIGHT study
3 November 2026 - US biotechnology company Ultima Genomics announced on Monday that its UG200 Sequencing Platform has been selected for the SG-INSIGHT study, a cohort under Phase III of Singapore's National Precision Medicine (NPM) programme, a ...
Lupin's Amifampridine Tablets approved by US FDA
3 November 2026 - India-based global pharmaceutical company Lupin Limited (BSE:500257) (NSE:LUPIN) announced on Monday that it has received approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Applications (ANDAs) for ...
Roche wins FDA clearance for customisable respiratory pathogen test
2 November 2026 - Healthcare company Roche (SIX: RO, ROP) (OTCQX: RHHBY) announced on Monday that it has received US Food and Drug Administration 510(k) clearance for its cobas eplex respiratory pathogen panel 3 (RP3), enabling laboratories to custom...
Abbott's Amulet 360 shows high LAA closure rates and low stroke incidence at one year
2 November 2026 - Healthcare company Abbott (NYSE: ABT) reported on Monday that it has achieved positive one-year results from the pivotal VERITAS study of its investigational Amulet 360 Left Atrial Appendage (LAA) Occluder, demonstrating high closur...
INOVIO's VOCERYQ receives US FDA accelerated approval to reduce surgery frequency in adults with RRP
2 November 2026 - INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercialising DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, announced on Friday that the US Food a...